Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

TKO GROUP HOLDINGS, INC. (TKO)

  • Business News
  • May 06, 2026, 20:05 UTC
  • 2
  • 1 comments

TKO Reports First Quarter 2026 Results

Market reaction Comment Full text

XPERI INC. (XPER)

  • Business News
  • May 06, 2026, 20:05 UTC
  • 3
  • 1 comments

Xperi Inc. Announces First Quarter 2026 Results

Market reaction Comment Full text

VIR BIOTECHNOLOGY, INC. (VIR)

  • Business News
  • May 06, 2026, 20:05 UTC
  • 2
  • 1 comments

Vir Biotechnology Provides Corporate Update and Reports First Quarter 2026 Financial Results

Market reaction Comment Full text

DUTCH BROS INC. (BROS)

  • Business News
  • May 06, 2026, 20:05 UTC
  • 3
  • 1 comments

Dutch Bros Inc. Reports First Quarter 2026 Financial Results

Market reaction Comment Full text

HYPERFINE, INC. (HYPR)

  • Business News
  • May 06, 2026, 20:05 UTC
  • 2
  • 1 comments

Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference

Market reaction Comment Full text

SAFETY INSURANCE GROUP INC (SAFT)

  • Business News
  • May 06, 2026, 20:05 UTC
  • 2
  • 1 comments

Safety Insurance Group, Inc. Announces First Quarter 2026 Results and Declares Second Quarter 2026 Dividend

Market reaction Comment Full text

ARRAY TECHNOLOGIES, INC. (ARRY)

  • Business News
  • May 06, 2026, 20:05 UTC
  • 2
  • 1 comments

ARRAY Technologies Reports Financial Results for the First Quarter 2026

Market reaction Comment Full text

SERA PROGNOSTICS, INC. (SERA)

  • Business News
  • May 06, 2026, 20:05 UTC
  • 2
  • 1 comments

SERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

Market reaction Comment Full text

DOCUSIGN, INC. (DOCU)

  • Business News
  • May 06, 2026, 20:05 UTC
  • 3
  • 1 comments

Docusign Appoints Rowan Trollope to Board of Directors

Market reaction Comment Full text

LYELL IMMUNOPHARMA, INC. (LYEL)

  • Business News
  • May 06, 2026, 20:05 UTC
  • 3
  • 1 comments

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026

Market reaction Comment Full text
  • Previous
  • 205
  • 206
  • 207
  • 208
  • 209
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158476)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin